Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years
Public ClinicalTrials.gov record NCT04895982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2b, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF VACCINE CANDIDATE BNT162b2 IN IMMUNOCOMPROMISED PARTICIPANTS ≥2 YEARS OF AGE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 4 dose study with 124 participants (7 adults ,117 children). Adults are considered to be participants 18 years of age or older. Participants are going to be enrolled based on conditions that make them immunocompromised. Participants are going to be followed up for 6 months after dose 4, and each participant is projected to be on the study for approximately 15 months. This study will be conducted in the United States, Brazil, Germany and Mexico.
Study identification
- NCT ID
- NCT04895982
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 14, 2021
- Primary completion
- Jul 22, 2023
- Completion
- Jul 22, 2023
- Last update posted
- Oct 8, 2024
2021 – 2023
United States locations
- U.S. sites
- 15
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ochsner Clinic Foundation | Jefferson | Louisiana | 70121 | — |
| Ochsner Medical Center - Jefferson Highway | Jefferson | Louisiana | 70121 | — |
| Ochsner Clinic Foundation | Kenner | Louisiana | 70065 | — |
| Ochsner Medical Center Kenner | Kenner | Louisiana | 70065 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Ochsner Medical Center - Jefferson Highway | New Orleans | Louisiana | 70121 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Henry Ford Hospital - Research Pharmacy | Detroit | Michigan | 48202 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45206 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Cincinnati Children's Hospital Vaccine Research Center | Cincinnati | Ohio | 45229 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
| Seattle Children's Research Institute: Building Cure | Seattle | Washington | 98101 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04895982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2024 · Synced Sep 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04895982 live on ClinicalTrials.gov.